MEDIROM Healthcare Technologies (NYSE:MRM) Stock Rating Upgraded by ThinkEquity

ThinkEquity upgraded shares of MEDIROM Healthcare Technologies (NYSE:MRM) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.

MEDIROM Healthcare Technologies Price Performance

Shares of NYSE:MRM opened at $0.94 on Monday. The business has a 50-day moving average price of $1.41 and a 200 day moving average price of $2.64. MEDIROM Healthcare Technologies has a 12-month low of $0.83 and a 12-month high of $8.39.

Hedge Funds Weigh In On MEDIROM Healthcare Technologies

A hedge fund recently bought a new stake in MEDIROM Healthcare Technologies stock. Virtu Financial LLC bought a new stake in MEDIROM Healthcare Technologies Inc. (NYSE:MRM) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 10,942 shares of the company’s stock, valued at approximately $33,000. Virtu Financial LLC owned approximately 0.22% of MEDIROM Healthcare Technologies at the end of the most recent reporting period.

About MEDIROM Healthcare Technologies

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.